JPS6152806B2 - - Google Patents

Info

Publication number: JPS6152806B2
Authority: JP; Japan
Prior art keywords: activity; active substance; sample; administered; cells
Prior art date: 1980-07-09
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

JP55094275A

Other languages

English (en)

Japanese (ja)

Other versions

JPS5718622A (en

Inventor

Yasuhiko Kojima

Yoshuki Konno

Sadao Tamamura

Takashi Hashimoto

Nobuyuki Shibukawa

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

KITAZATO KENKYUSHO

Original Assignee

KITAZATO KENKYUSHO

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1980-07-09

Filing date

1980-07-09

Publication date

1986-11-14

1980-07-09 Application filed by KITAZATO KENKYUSHO filed Critical KITAZATO KENKYUSHO

1980-07-09 Priority to JP9427580A priority Critical patent/JPS5718622A/ja

1982-01-30 Publication of JPS5718622A publication Critical patent/JPS5718622A/ja

1986-11-14 Publication of JPS6152806B2 publication Critical patent/JPS6152806B2/ja

Status Granted legal-status Critical Current

Links

239000013543 active substance Substances 0.000 claims description 28
230000001939 inductive effect Effects 0.000 claims description 13
235000003261 Artemisia vulgaris Nutrition 0.000 claims description 9
241000196324 Embryophyta Species 0.000 claims description 8
239000000203 mixture Substances 0.000 claims description 8
240000006891 Artemisia vulgaris Species 0.000 claims description 7
239000004480 active ingredient Substances 0.000 claims description 7
239000000546 pharmaceutical excipient Substances 0.000 claims description 4
102000014150 Interferons Human genes 0.000 claims description 3
108010050904 Interferons Proteins 0.000 claims description 3
229940079322 interferon Drugs 0.000 claims description 3
235000003826 Artemisia Nutrition 0.000 claims description 2
241000208838 Asteraceae Species 0.000 claims description 2
235000009052 artemisia Nutrition 0.000 claims description 2
239000003937 drug carrier Substances 0.000 claims description 2
238000000034 method Methods 0.000 description 39
230000000694 effects Effects 0.000 description 31
239000000523 sample Substances 0.000 description 27
241001465754 Metazoa Species 0.000 description 22
241000283973 Oryctolagus cuniculus Species 0.000 description 21
238000012360 testing method Methods 0.000 description 19
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
210000004027 cell Anatomy 0.000 description 17
239000000126 substance Substances 0.000 description 16
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
239000000843 powder Substances 0.000 description 15
241000699670 Mus sp. Species 0.000 description 13
238000004519 manufacturing process Methods 0.000 description 13
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
239000000411 inducer Substances 0.000 description 11
241000699666 Mus <mouse, genus> Species 0.000 description 10
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
241000282412 Homo Species 0.000 description 9
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
241000700605 Viruses Species 0.000 description 8
239000002504 physiological saline solution Substances 0.000 description 8
210000002966 serum Anatomy 0.000 description 8
241000700618 Vaccinia virus Species 0.000 description 7
LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 6
KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
210000004369 blood Anatomy 0.000 description 6
239000008280 blood Substances 0.000 description 6
238000005259 measurement Methods 0.000 description 6
239000002994 raw material Substances 0.000 description 6
230000004071 biological effect Effects 0.000 description 5
238000000605 extraction Methods 0.000 description 5
238000000338 in vitro Methods 0.000 description 5
230000002265 prevention Effects 0.000 description 5
239000012264 purified product Substances 0.000 description 5
239000000243 solution Substances 0.000 description 5
239000008223 sterile water Substances 0.000 description 5
239000003826 tablet Substances 0.000 description 5
231100000419 toxicity Toxicity 0.000 description 5
230000001988 toxicity Effects 0.000 description 5
210000003462 vein Anatomy 0.000 description 5
235000003097 Artemisia absinthium Nutrition 0.000 description 4
240000001851 Artemisia dracunculus Species 0.000 description 4
241000287828 Gallus gallus Species 0.000 description 4
206010028980 Neoplasm Diseases 0.000 description 4
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
241000700647 Variola virus Species 0.000 description 4
238000000862 absorption spectrum Methods 0.000 description 4
239000007864 aqueous solution Substances 0.000 description 4
239000006285 cell suspension Substances 0.000 description 4
239000003795 chemical substances by application Substances 0.000 description 4
235000013330 chicken meat Nutrition 0.000 description 4
230000006698 induction Effects 0.000 description 4
208000015181 infectious disease Diseases 0.000 description 4
238000007912 intraperitoneal administration Methods 0.000 description 4
238000001990 intravenous administration Methods 0.000 description 4
239000007788 liquid Substances 0.000 description 4
238000000746 purification Methods 0.000 description 4
239000000829 suppository Substances 0.000 description 4
238000000108 ultra-filtration Methods 0.000 description 4
235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 3
235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 3
244000065027 Artemisia princeps Species 0.000 description 3
235000017519 Artemisia princeps Nutrition 0.000 description 3
241000700159 Rattus Species 0.000 description 3
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
241000711975 Vesicular stomatitis virus Species 0.000 description 3
235000001014 amino acid Nutrition 0.000 description 3
229940024606 amino acid Drugs 0.000 description 3
150000001413 amino acids Chemical class 0.000 description 3
239000001138 artemisia absinthium Substances 0.000 description 3
230000037396 body weight Effects 0.000 description 3
238000006243 chemical reaction Methods 0.000 description 3
239000012535 impurity Substances 0.000 description 3
238000002347 injection Methods 0.000 description 3
239000007924 injection Substances 0.000 description 3
238000005342 ion exchange Methods 0.000 description 3
231100000053 low toxicity Toxicity 0.000 description 3
210000004379 membrane Anatomy 0.000 description 3
239000012528 membrane Substances 0.000 description 3
239000003960 organic solvent Substances 0.000 description 3
239000002244 precipitate Substances 0.000 description 3
239000000047 product Substances 0.000 description 3
230000035755 proliferation Effects 0.000 description 3
BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
230000004043 responsiveness Effects 0.000 description 3
KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 3
239000006228 supernatant Substances 0.000 description 3
230000004083 survival effect Effects 0.000 description 3
239000000725 suspension Substances 0.000 description 3
239000006188 syrup Substances 0.000 description 3
235000020357 syrup Nutrition 0.000 description 3
238000002054 transplantation Methods 0.000 description 3
230000009385 viral infection Effects 0.000 description 3
238000005406 washing Methods 0.000 description 3
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
241000092668 Artemisia capillaris Species 0.000 description 2
240000004950 Artemisia lactiflora Species 0.000 description 2
235000004355 Artemisia lactiflora Nutrition 0.000 description 2
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
229920002472 Starch Polymers 0.000 description 2
241000282887 Suidae Species 0.000 description 2
102000004142 Trypsin Human genes 0.000 description 2
108090000631 Trypsin Proteins 0.000 description 2
208000036142 Viral infection Diseases 0.000 description 2
230000002378 acidificating effect Effects 0.000 description 2
229910000147 aluminium phosphate Inorganic materials 0.000 description 2
239000003708 ampul Substances 0.000 description 2
230000000259 anti-tumor effect Effects 0.000 description 2
244000309466 calf Species 0.000 description 2
201000011510 cancer Diseases 0.000 description 2
239000002775 capsule Substances 0.000 description 2
239000000969 carrier Substances 0.000 description 2
230000008859 change Effects 0.000 description 2
238000007796 conventional method Methods 0.000 description 2
239000003814 drug Substances 0.000 description 2
238000010828 elution Methods 0.000 description 2
230000003203 everyday effect Effects 0.000 description 2
235000013305 food Nutrition 0.000 description 2
230000036541 health Effects 0.000 description 2
235000008216 herbs Nutrition 0.000 description 2
230000007062 hydrolysis Effects 0.000 description 2
238000006460 hydrolysis reaction Methods 0.000 description 2
238000001727 in vivo Methods 0.000 description 2
230000005764 inhibitory process Effects 0.000 description 2
238000010253 intravenous injection Methods 0.000 description 2
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
238000002844 melting Methods 0.000 description 2
230000008018 melting Effects 0.000 description 2
239000002674 ointment Substances 0.000 description 2
-1 plasters Substances 0.000 description 2
230000037452 priming Effects 0.000 description 2
239000011734 sodium Substances 0.000 description 2
239000011780 sodium chloride Substances 0.000 description 2
210000000952 spleen Anatomy 0.000 description 2
210000004989 spleen cell Anatomy 0.000 description 2
239000007921 spray Substances 0.000 description 2
239000008107 starch Substances 0.000 description 2
235000019698 starch Nutrition 0.000 description 2
231100000456 subacute toxicity Toxicity 0.000 description 2
210000001519 tissue Anatomy 0.000 description 2
239000012588 trypsin Substances 0.000 description 2
238000005199 ultracentrifugation Methods 0.000 description 2
JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
241000251468 Actinopterygii Species 0.000 description 1
240000007241 Agrostis stolonifera Species 0.000 description 1
235000019489 Almond oil Nutrition 0.000 description 1
244000043798 Ambrosia paniculata Species 0.000 description 1
VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
241000272517 Anseriformes Species 0.000 description 1
239000004475 Arginine Substances 0.000 description 1
244000249062 Artemisia abrotanum Species 0.000 description 1
240000002877 Artemisia absinthium Species 0.000 description 1
241001670245 Artemisia arbuscula Species 0.000 description 1
235000015701 Artemisia arbuscula Nutrition 0.000 description 1
241001213048 Artemisia biennis Species 0.000 description 1
241001249193 Artemisia campestris Species 0.000 description 1
241000647598 Artemisia campestris subsp. caudata Species 0.000 description 1
241001168899 Artemisia feddei Species 0.000 description 1
241001670242 Artemisia filifolia Species 0.000 description 1
240000004573 Artemisia frigida Species 0.000 description 1
244000065355 Artemisia glacialis Species 0.000 description 1
241000271889 Artemisia japonica Species 0.000 description 1
241001168905 Artemisia keiskeana Species 0.000 description 1
241000505512 Artemisia kurramensis Species 0.000 description 1
241000079358 Artemisia lindleyana Species 0.000 description 1
244000267790 Artemisia ludoviciana Species 0.000 description 1
240000008118 Artemisia maritima Species 0.000 description 1
241001249191 Artemisia molinieri Species 0.000 description 1
241000638253 Artemisia montana Species 0.000 description 1
244000252230 Artemisia stelleriana Species 0.000 description 1
241000544343 Artemisia tridentata Species 0.000 description 1
235000002657 Artemisia tridentata Nutrition 0.000 description 1
206010003445 Ascites Diseases 0.000 description 1
241000271566 Aves Species 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
102000004961 Furin Human genes 0.000 description 1
108090001126 Furin Proteins 0.000 description 1
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
208000009889 Herpes Simplex Diseases 0.000 description 1
101000999325 Homo sapiens Cobalamin binding intrinsic factor Proteins 0.000 description 1
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
239000004166 Lanolin Substances 0.000 description 1
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
241000256259 Noctuidae Species 0.000 description 1
241001327682 Oncorhynchus mykiss irideus Species 0.000 description 1
241001600434 Plectroglyphidodon lacrymatus Species 0.000 description 1
108091036414 Polyinosinic:polycytidylic acid Proteins 0.000 description 1
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
229920005654 Sephadex Polymers 0.000 description 1
239000012507 Sephadex™ Substances 0.000 description 1
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
241000700584 Simplexvirus Species 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
239000004473 Threonine Substances 0.000 description 1
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
241000251539 Vertebrata <Metazoa> Species 0.000 description 1
230000005856 abnormality Effects 0.000 description 1
239000002253 acid Substances 0.000 description 1
230000009471 action Effects 0.000 description 1
230000007059 acute toxicity Effects 0.000 description 1
231100000403 acute toxicity Toxicity 0.000 description 1
235000004279 alanine Nutrition 0.000 description 1
239000008168 almond oil Substances 0.000 description 1
229910021529 ammonia Inorganic materials 0.000 description 1
235000019270 ammonium chloride Nutrition 0.000 description 1
239000000908 ammonium hydroxide Substances 0.000 description 1
150000003863 ammonium salts Chemical class 0.000 description 1
BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
229910052921 ammonium sulfate Inorganic materials 0.000 description 1
235000011130 ammonium sulphate Nutrition 0.000 description 1
238000005349 anion exchange Methods 0.000 description 1
150000001450 anions Chemical class 0.000 description 1
230000000840 anti-viral effect Effects 0.000 description 1
239000002246 antineoplastic agent Substances 0.000 description 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
235000003704 aspartic acid Nutrition 0.000 description 1
210000001099 axilla Anatomy 0.000 description 1
239000003788 bath preparation Substances 0.000 description 1
235000013871 bee wax Nutrition 0.000 description 1
239000012166 beeswax Substances 0.000 description 1
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
238000010241 blood sampling Methods 0.000 description 1
238000009835 boiling Methods 0.000 description 1
210000001185 bone marrow Anatomy 0.000 description 1
238000005341 cation exchange Methods 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
238000004440 column chromatography Methods 0.000 description 1
235000008504 concentrate Nutrition 0.000 description 1
239000012141 concentrate Substances 0.000 description 1
ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 1
239000012043 crude product Substances 0.000 description 1
238000012258 culturing Methods 0.000 description 1
MAEBCGDGGATMSC-OSHGGGOQSA-N cyclamine Chemical compound O([C@H]1CO[C@H]([C@@H]([C@H]1O[C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O[C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@H]1CC[C@]2(C)[C@H]3CCC45OCC6([C@@H](C[C@@]4(C)[C@]3(C)CCC2C1(C)C)O)CC[C@@](C[C@@H]65)(C)C=O)[C@@H]1OC[C@@H](O)[C@H](O)[C@H]1O MAEBCGDGGATMSC-OSHGGGOQSA-N 0.000 description 1
230000002354 daily effect Effects 0.000 description 1
238000000354 decomposition reaction Methods 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
239000002270 dispersing agent Substances 0.000 description 1
239000002552 dosage form Substances 0.000 description 1
239000006196 drop Substances 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
238000000921 elemental analysis Methods 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
239000003889 eye drop Substances 0.000 description 1
229940012356 eye drops Drugs 0.000 description 1
239000012091 fetal bovine serum Substances 0.000 description 1
239000000945 filler Substances 0.000 description 1
238000001914 filtration Methods 0.000 description 1
239000012467 final product Substances 0.000 description 1
239000012847 fine chemical Substances 0.000 description 1
238000009472 formulation Methods 0.000 description 1
239000003205 fragrance Substances 0.000 description 1
238000004108 freeze drying Methods 0.000 description 1
239000003349 gelling agent Substances 0.000 description 1
235000013922 glutamic acid Nutrition 0.000 description 1
239000004220 glutamic acid Substances 0.000 description 1
235000011187 glycerol Nutrition 0.000 description 1
239000008187 granular material Substances 0.000 description 1
230000003862 health status Effects 0.000 description 1
231100000086 high toxicity Toxicity 0.000 description 1
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
230000006872 improvement Effects 0.000 description 1
229940060367 inert ingredients Drugs 0.000 description 1
208000014674 injury Diseases 0.000 description 1
239000002054 inoculum Substances 0.000 description 1
239000007927 intramuscular injection Substances 0.000 description 1
238000010255 intramuscular injection Methods 0.000 description 1
239000007928 intraperitoneal injection Substances 0.000 description 1
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
229960000310 isoleucine Drugs 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
239000008101 lactose Substances 0.000 description 1
235000019388 lanolin Nutrition 0.000 description 1
229940039717 lanolin Drugs 0.000 description 1
210000000265 leukocyte Anatomy 0.000 description 1
239000000865 liniment Substances 0.000 description 1
239000007937 lozenge Substances 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
210000001165 lymph node Anatomy 0.000 description 1
210000004698 lymphocyte Anatomy 0.000 description 1
235000019359 magnesium stearate Nutrition 0.000 description 1
238000000691 measurement method Methods 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
238000004264 monolayer culture Methods 0.000 description 1
210000004400 mucous membrane Anatomy 0.000 description 1
FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
239000003921 oil Substances 0.000 description 1
235000019198 oils Nutrition 0.000 description 1
239000003973 paint Substances 0.000 description 1
PIRWNASAJNPKHT-SHZATDIYSA-N pamp Chemical compound C([C@@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)N)C(C)C)C1=CC=CC=C1 PIRWNASAJNPKHT-SHZATDIYSA-N 0.000 description 1
238000007911 parenteral administration Methods 0.000 description 1
239000008194 pharmaceutical composition Substances 0.000 description 1
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
230000001766 physiological effect Effects 0.000 description 1
229940093430 polyethylene glycol 1500 Drugs 0.000 description 1
229940068918 polyethylene glycol 400 Drugs 0.000 description 1
229940115272 polyinosinic:polycytidylic acid Drugs 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
229920001592 potato starch Polymers 0.000 description 1
238000004321 preservation Methods 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
230000008569 process Effects 0.000 description 1
238000012545 processing Methods 0.000 description 1
235000018102 proteins Nutrition 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
230000009467 reduction Effects 0.000 description 1
230000004044 response Effects 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
239000012488 sample solution Substances 0.000 description 1
239000007787 solid Substances 0.000 description 1
239000002904 solvent Substances 0.000 description 1
241000894007 species Species 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
238000003756 stirring Methods 0.000 description 1
238000010254 subcutaneous injection Methods 0.000 description 1
239000007929 subcutaneous injection Substances 0.000 description 1
239000000375 suspending agent Substances 0.000 description 1
238000011200 topical administration Methods 0.000 description 1
230000008733 trauma Effects 0.000 description 1
210000004881 tumor cell Anatomy 0.000 description 1
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
210000003934 vacuole Anatomy 0.000 description 1
239000004474 valine Substances 0.000 description 1
230000004584 weight gain Effects 0.000 description 1
235000019786 weight gain Nutrition 0.000 description 1
239000003871 white petrolatum Substances 0.000 description 1
239000011592 zinc chloride Substances 0.000 description 1
235000005074 zinc chloride Nutrition 0.000 description 1

Landscapes

Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Plant Substances (AREA)

JP9427580A 1980-07-09 1980-07-09 Use of interferon inducer Granted JPS5718622A (en)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
JP9427580A JPS5718622A (en)	1980-07-09	1980-07-09	Use of interferon inducer

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP9427580A JPS5718622A (en)	1980-07-09	1980-07-09	Use of interferon inducer

Publications (2)

Publication Number	Publication Date
JPS5718622A JPS5718622A (en)	1982-01-30
JPS6152806B2 true JPS6152806B2 (fr)	1986-11-14

Family

ID=14105705

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP9427580A Granted JPS5718622A (en)	1980-07-09	1980-07-09	Use of interferon inducer

Country Status (1)

Country	Link
JP (1)	JPS5718622A (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100904396B1 (ko) *	2007-10-24	2009-06-26	주식회사 알앤엘바이오	인진쑥을 유효성분으로 함유하는 산유량 증가용 조성물

1980
- 1980-07-09 JP JP9427580A patent/JPS5718622A/ja active Granted

Also Published As

Publication number	Publication date
JPS5718622A (en)	1982-01-30

Publication	Publication Date	Title
JPH08500589A (ja)	1996-01-23	アストラガルスポリサッカライド免疫調節剤
CA1338849C (fr)	1997-01-14	Lectines et medicaments antiretroviraux renfermant les lectines comme ingredients actifs
US4271151A (en)	1981-06-02	Protein-bound polysaccharides
CS200503B2 (en)	1980-09-15	Method of preparation of the antigall substances
SU704431A3 (ru)	1979-12-15	Способ получени полисахаридов, обладающих противоопухолевым действием
DE69113978T2 (de)	1996-03-21	Anti-hiv mittel.
US4419349A (en)	1983-12-06	Interferon inducer, a process for producing the same and pharmaceutical composition containing the same
JPH0641416B2 (ja)	1994-06-01	植物起源の生物活性物質の製造法および同物質含有組成物
KR920002935B1 (ko)	1992-04-10	맥관 형성 저해제
CA1339308C (fr)	1997-08-19	Polysaccharides et medicament antiviral renfermant des polysaccharides comme ingredients actifs
US4614733A (en)	1986-09-30	Polysaccharides pharmaceutical compositions and the use thereof
EP0382551B1 (fr)	1993-11-10	Prophylaxie et traitement des infections à virus de l'herpes
JPS6152807B2 (fr)	1986-11-14
US4442087A (en)	1984-04-10	Interferon inducer, a process for producing the same and pharmaceutical composition containing the same
JPS6152806B2 (fr)	1986-11-14
GB2042555A (en)	1980-09-24	Interferon inducers, methods for their preparation, pharmaceutical compositions containing them and their use as medicaments
US6015796A (en)	2000-01-18	Method for treating AIDS
US4440761A (en)	1984-04-03	Interferon inducer, a process for producing the same and pharmaceutical composition containing the same
JP3129751B2 (ja)	2001-01-31	ブナシメジ子実体熱水抽出物
JPH0248000B2 (fr)	1990-10-23
US5283239A (en)	1994-02-01	Inhibitor of herpesvirus absorption
GB2042558A (en)	1980-09-24	Interferon inducers, methods for their preparation, pharmaceutical compositions containing them and their use as medicaments
JP3254567B2 (ja)	2002-02-12	植物組織からの生理活性物質の製造方法及びこの物質を含有する組成物
US3584123A (en)	1971-06-08	Method of treatment of skin diseases and therapeutic products from the roots of securidaca longipedonculata
KR810001499B1 (ko)	1981-10-25	질소를 함유하는 다당류의 제조방법